239 related articles for article (PubMed ID: 30093324)
1. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
[TBL] [Abstract][Full Text] [Related]
2. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.
Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F
Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
5. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.
Grisendi G; Spano C; D'souza N; Rasini V; Veronesi E; Prapa M; Petrachi T; Piccinno S; Rossignoli F; Burns JS; Fiorcari S; Granchi D; Baldini N; Horwitz EM; Guarneri V; Conte P; Paolucci P; Dominici M
Stem Cells; 2015 Mar; 33(3):859-69. PubMed ID: 25420617
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model.
Un Choi Y; Yoon Y; Jung PY; Hwang S; Hong JE; Kim WS; Sohn JH; Rhee KJ; Bae KS; Eom YW
Cancer Genomics Proteomics; 2021; 18(4):569-578. PubMed ID: 34183389
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
[TBL] [Abstract][Full Text] [Related]
12. Engineered human mesenchymal stem cells for neuroblastoma therapeutics.
Nieddu V; Piredda R; Bexell D; Barton J; Anderson J; Sebire N; Kolluri K; Janes SM; Karteris E; Sala A
Oncol Rep; 2019 Jul; 42(1):35-42. PubMed ID: 31115546
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
14. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
15. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
Xiao F; Chen J; Lian C; Han P; Zhang C
Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.
Yuan Z; Kolluri KK; Sage EK; Gowers KH; Janes SM
Cytotherapy; 2015 Jul; 17(7):885-96. PubMed ID: 25888191
[TBL] [Abstract][Full Text] [Related]
18. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
[TBL] [Abstract][Full Text] [Related]
19. CYC1 silencing sensitizes osteosarcoma cells to TRAIL-induced apoptosis.
Li G; Fu D; Liang W; Fan L; Chen K; Shan L; Hu S; Ma X; Zhou K; Cheng B
Cell Physiol Biochem; 2014; 34(6):2070-80. PubMed ID: 25562155
[TBL] [Abstract][Full Text] [Related]
20. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
